ripekg:evaluation/RIPEA5A5547915735AD6D |
prov:wasInformedBy |
ripekg:evidence-aggregation/RIPEA5A5547915735AD6D |
ripekg:evidence-aggregation/RIPEA5A5547915735AD6D |
rdf:type |
rdfs:Resource |
ripekg:evidence-aggregation/RIPEA5A5547915735AD6D |
rdf:type |
owl:Thing |
ripekg:evidence-aggregation/RIPEA5A5547915735AD6D |
rdf:type |
ripe:EvidenceAggregationEvidence aggregation |
ripekg:evidence-aggregation/RIPEA5A5547915735AD6D |
rdf:type |
tido:Activity |
ripekg:evidence-aggregation/RIPEA5A5547915735AD6D |
prov:startedAtTime |
2026-02-26T13:29:27.149852Z |
ripekg:evidence-aggregation/RIPEA5A5547915735AD6D |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0 |
ripekg:evidence-aggregation/RIPEA5A5547915735AD6D |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI |
ripekg:evidence-aggregation/RIPEA5A5547915735AD6D |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEA5A5547915735AD6D |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA5A5547915735AD6D |
ripekg:registry-evidence/RIPEA5A5547915735AD6D |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA5A5547915735AD6D |
ripekg:study-design-evidence/RIPEA5A5547915735AD6D |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA5A5547915735AD6D |